MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 3061-3070 Newer>
The Motley Fool
August 6, 2004
Zeke Ashton
Are Biotechs Worth the Risk? Even when their drugs are doing well, companies in this industry don't necessarily yield big rewards for investors. mark for My Articles 66 similar articles
The Motley Fool
August 6, 2004
Rich Smith
Titan Shrugs Off Merger Mess Failed merger notwithstanding, the defense contractor looks more or less healthy. mark for My Articles 43 similar articles
The Motley Fool
August 6, 2004
Avoiding Research Errors How can you avoid making errors with numbers as you research companies and calculate various measures? One good rule of thumb is to check your work by doing the math a second time. mark for My Articles 27 similar articles
The Motley Fool
August 6, 2004
Rick Aristotle Munarriz
The Need for eSpeed The promise of active income investing isn't enough to let eSpeed take off. mark for My Articles 27 similar articles
BusinessWeek
August 16, 2004
Gene G. Marcial
Patterson: Really Drilling Stock in the No. 2 provider of onshore-drilling services to oil-and-gas producers is now at 17.36 -- and some pros see it hitting 25. mark for My Articles 62 similar articles
BusinessWeek
August 16, 2004
Dean Foust
Things Aren't Going Better At Coke New CEO E. Neville Isdell entered to good news. But with the bottling company no longer calling the shots, he is finding that there's no quick or easy way to get the fizz back into Coke. And investors are fretting. mark for My Articles 187 similar articles
BusinessWeek
August 16, 2004
Gene G. Marcial
Are Rivals Giving Dover The Once-Over? Dover Downs Gaming & Entertainment looks attractive to some casino/racino operators. Now at $9.77, the company could be worth $15. mark for My Articles 137 similar articles
BusinessWeek
August 16, 2004
Gene G. Marcial
Profits Loom For AEterna Zentaris The little-known Canadian biopharma has an array of cancer products that could push it to profitability after years of losses. The stock, now at $4.15, could reach $12 in a year. mark for My Articles 52 similar articles
InternetNews
August 5, 2004
Susan Kuchinskas
Google Flunks Governance With an insider board and improper securities sales, who's minding the store? mark for My Articles 709 similar articles
The Motley Fool
August 5, 2004
Bill Mann
InterActive Complications InterActive Corp. may offer an opportunity, but please don't take the company on faith. The company he runs saw its stock crater yesterday after it reported revenue growth of only 20%. mark for My Articles 94 similar articles
<Older 3061-3070 Newer>    Return to current articles.